New Chromabond® Drug Ii
May 15 2007
CHROMABONDÂ® Drug II contains a bifunctional adsorbent material, consisting from a strong anion exchanger (SAX, quaternary amine) and C8 modified silica. Two primary retention mechanisms facilitate the use of very strong interferant eluting solvents resulting in very pure extracts especially from heavily matrix loaded samples like urine, plasma, serum or whole blood.
Already available from Macaherey Nagel is CHROMABONDÂ® Drug a SPE-cartridge for enrichment of acidic, neutral and basic drugs. By introducing CHROMABONDÂ® Drug II the scope of SPE products for drug analysis is widened by the important group of THCs.
In This Edition Chromatography Articles - Comparing techniques for flow rate measurement in Liquid Chromatography Mass Spectrometry & Spectroscopy Articles - APGC: A Better Future with...
View all digital editions
Mar 04 2024 Guanghzou, China
Mar 05 2024 Guangzhou, China
Mar 14 2024 Brussels, Belgium
Mar 17 2024 Monterey, CA, USA
Mar 17 2024 New Orleans, LA, USA